Aaron Kantoff
InvestorManaging Partner at Scion Life Sciences Β· Board director at Rayze Bio
New York, New York, United States
About
Aaron Kantoff is a founder and Managing Partner of Scion, with about 15 years spent founding, building, and investing in life sciences companies focused on therapeutics. He was previously a Venture Partner at Medicxi and a Partner at Apple Tree Partners, where he helped launch several portfolio companies and worked on crossover and public biotech investments. He holds a B.S. in Finance and International Business from NYU's Stern School of Business.
ContactΒ· self-published, not guessed
Invests in
Biotech
Board director at Rayze Bio
Intro paths
In turn, Aaron can intro founders to Rayze Bio's investors below.
Rayze Bio's investors Β· 8
Co-founders at Rayze Bio
Experience
- Scion Life SciencesCo-Founder & Managing Partnercurrent2022 β presentNew York
- Avalo TherapeuticsBoard Membercurrent2024 β presentWayne, Pennsylvania, United States
- The Lustgarten FoundationBoard Membercurrent2024 β presentNew York City Metropolitan Area
- Tourmaline BioBoard Member2022 β 2025New York
- RayzeBioFounding Board Member2020 β 2024San Diego, California, United States
- Centessa PharmaceuticalsBoard Member2020 β 2022Cambridge, Massachusetts & London, UK
- medicxiVenture Partner2020 β 2021
- Akero TherapeuticsBoard Member2017 β 2019San Francisco Bay Area
- Corvidia TherapeuticsBoard Member2016 β 2019Greater Boston Area
- Elstar Therapeutics Inc. (now Marengo Therapeutics)Board Member2015 β 2019Cambridge, MA
- Apple Tree PartnersPartner2011 β 2019Greater New York City Area
- Limelight Bio (now Ascidian)Board Member2016 β 2019Greater Philadelphia Area
- SyntimmuneBoard Member2014 β 2018Greater Boston Area
- Braeburn Pharmaceuticals, Inc.Executive Director, Business Development and Corporate Strategy2012 β 2014Princeton, New Jersey
Skills & more
+1 more
Pharmaceutical IndustryFrom Aaron's professional profile.
Investments
Board seats
AkeroAscidianAvalo TherapeuticsCentessa Pharmaceuticals PLCCorvidia TherapeuticsMarengoRayze BioStoke TherapeuticsSyntimmuneTourmaline Bio
Per the firm's website.
Colleagues at Scion Life Sciences
Frequently asked questions
- Who is Aaron Kantoff?
- Aaron Kantoff is a founder and Managing Partner of Scion, with about 15 years spent founding, building, and investing in life sciences companies focused on therapeutics. He was previously a Venture Partner at Medicxi and a Partner at Apple Tree Partners, where he helped launch several portfolio companies and worked on crossover and public biotech investments. He holds a B.S. in Finance and International Business from NYU's Stern School of Business.
- Where does Aaron Kantoff work?
- Aaron Kantoff is Managing Partner at Scion Life Sciences and Board director at Rayze Bio.
- What does Aaron Kantoff invest in?
- Aaron Kantoff invests in Biotech.
- What boards does Aaron Kantoff sit on?
- Aaron Kantoff holds tracked board seats at Akero, Ascidian, Avalo Therapeutics, Centessa Pharmaceuticals PLC, Corvidia Therapeutics, Marengo, Rayze Bio, Stoke Therapeutics, Syntimmune, Tourmaline Bio.
- Where did Aaron Kantoff go to school?
- Aaron Kantoff studied at New York University - Leonard N. Stern School of Business (B.S., Finance and International Business).
Same school
Also attended New York University - Leonard N. Stern School of Business430
+ 424 more
Shared employers
Also worked at medicxi23
+ 17 more
Also worked at Akero Therapeutics5
Also worked at Apple Tree Partners8
+ 2 more







































